Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 752,157 | 640,799 | 651,634 | 578,165 | 544,135 |
| Cost of Goods | 104,382 | 71,613 | 84,052 | 72,874 | 71,205 |
| Gross Profit | 647,775 | 569,186 | 567,582 | 505,291 | 472,930 |
| Operating Expenses | 475,279 | 440,898 | 441,897 | 832,208 | 420,428 |
| Operating Income | 172,878 | 128,901 | 125,737 | -326,043 | 52,707 |
| Interest Expense | 18,155 | 16,886 | 24,295 | 13,574 | 14,664 |
| Other Income | 61,868 | 102,627 | 11,000 | -77,553 | -2,537 |
| Pre-tax Income | 216,591 | 214,642 | 112,442 | -417,170 | 35,506 |
| Income Tax | 10,341 | -12,659 | 10,257 | -125,903 | 4,337 |
| Net Income Continuous | 206,250 | 227,301 | 102,185 | -291,267 | 31,169 |
| Minority Interests | -1,110 | 17,038 | 1,501 | -188,315 | 13,173 |
| Net Income | $207,360 | $210,263 | $100,684 | $-102,952 | $17,996 |
| EPS Basic Total Ops | 0.82 | 0.83 | 0.39 | -0.41 | 0.07 |
| EPS Basic Continuous Ops | 0.81 | 0.90 | 0.39 | -1.16 | 0.13 |
| EPS Diluted Total Ops | 0.80 | 0.81 | 0.39 | -0.41 | 0.07 |
| EPS Diluted Continuous Ops | 0.80 | 0.88 | 0.40 | -1.16 | 0.12 |
| EBITDA(a) | $190,937 | $145,244 | $142,169 | $-310,818 | $67,597 |